SEC Filing Summary
Registrant discrepancy: The supplied filing is for Tempur Sealy International, Inc., not SomniGroup International Inc. This summary reflects the filing’s named registrant.
Business context and reporting period
Unaudited Form 10-Q for the quarter and six months ended June 30, 2015; year-over-year comparisons are to 2014. Tempur Sealy develops, manufactures and sells bedding products and licenses brands. Effective January 1, 2015, it reported North America and International segments.
Financial performance
| Metric | Q2 2015 | Q2 2014 | Six months 2015 | Six months 2014 |
|---|---|---|---|---|
| Net sales | $764.4 million | $715.0 million | $1,503.9 million | $1,416.9 million |
| Gross profit / margin | $297.5 million / 38.9% | $268.3 million / 37.5% | $576.2 million / 38.3% | $537.8 million / 38.0% |
| Operating income / margin | $52.0 million / 6.8% | $50.3 million / 7.0% | $106.4 million / 7.1% | $112.7 million / 8.0% |
| Net income attributable to Tempur Sealy | $21.2 million | $(2.2) million | $44.6 million | $25.2 million |
| Diluted EPS | $0.34 | $(0.04) | $0.72 | $0.41 |
- Q2 reported sales rose 6.9% (10.9% at constant currency); six-month sales rose 6.1% (10.2% at constant currency). North America grew 9.1% in Q2 and 8.3% for the half. International sales fell 2.2% and 2.4%, respectively, but grew 14.1% and 13.3% at constant currency.
- Q2 gross margin improved 140 basis points, led by sourcing and supply-chain improvements and pricing, partly offset by product mix. Six-month gross margin improved 30 basis points.
- Q2 GAAP net income benefited from the absence of the prior-year $20.4 million loss on disposal of innerspring facilities. Adjusted Q2 net income was $33.3 million versus $24.0 million; adjusted diluted EPS was $0.53 versus $0.39. These are company-defined non-GAAP measures.
- For the first half, GAAP operating income declined 5.6% despite higher sales. Higher selling, administrative, integration and corporate costs offset gross-profit growth.
Cash flow, balance sheet and debt
- First-half operating cash flow was $1.1 million, down from $72.4 million. Management attributed the decline mainly to working-capital use and $36.9 million more cash income-tax payments year over year. Investing used $26.9 million; financing used $5.7 million.
- Cash was $35.4 million at June 30, down from $62.5 million at year-end. Working capital was $238.4 million. Capital expenditures were $34.0 million for the half.
- Total debt was $1,576.0 million, down from $1,602.3 million at year-end; stockholders’ equity was $252.7 million. Revolver availability was $298.2 million. The company reported a 3.83x funded-debt-less-qualified-cash-to-credit-agreement-EBITDA ratio, within its 4.75x covenant limit, and said it was in compliance with covenants.
- Debt includes $107.4 million of 8.0% Sealy Notes due July 2016, $375.0 million of 6.875% senior notes due 2020, and variable-rate credit facilities. About $943.6 million was variable-rate debt after the interest-rate swap; a 100-basis-point rate increase was estimated to reduce pretax income by about $9.4 million.
Outlook, management commentary and material risks
- Management expected significant operating cash flow generation in the second half of 2015, similar to the second half of 2014, and forecast 2015 capital expenditures of $60 million to $65 million. It did not provide a clear numerical revenue or EPS forecast in the supplied filing text.
- Management expected North America gross margin to benefit from sourcing, operational efficiencies and pricing, partly offset by lower International margins from Sealy product introductions and foreign exchange. Integration work was expected to continue through 2016, with expenses expected to decline in the second half of 2015 and in 2016. No significant new product introductions were expected for the rest of 2015.
- Foreign exchange reduced reported net income by an estimated 11.8% in Q2 and 18.1% for the first half; management expected continued adverse currency effects in the second half.
- Material unusual Q2 costs included $7.1 million of CEO transition expense, $4.2 million related to the 2015 Annual Meeting and related issues, and $6.7 million of Sealy integration costs. The filing also describes senior management and board changes and stockholder activism.
- Danish tax assessments for 2001–2008 totaled about $198.8 million, including interest and penalties; the company disputed them. A preliminary, non-binding case-manager recommendation favored the tax authority, and further assessments for 2009–2015 were expected to exceed the earlier assessed amounts. The company said adverse resolution could materially affect liquidity and profitability.
- A German antitrust investigation remained unresolved, with no formal claims asserted; the company had accrued no amount and could not estimate potential loss. Other contingencies include consumer class-action litigation and environmental remediation; recorded environmental reserves included $2.4 million for South Brunswick and about $0.1 million for Oakville.
- Customer concentration increased: the top five customers represented 41.0% of Q2 sales, and Mattress Firm alone exceeded 10% of sales. Management also cited competition, product-mix pressure, integration execution, leverage and the possibility of insufficient cash generation as risks.
Important facts for investors to verify
- Confirm the intended issuer: the filing names Tempur Sealy International, Inc., not SomniGroup International Inc.
- Track operating cash conversion, working capital and the expected second-half cash-flow recovery.
- Monitor debt reduction, the 2016 Sealy Notes maturity, variable-rate exposure and covenant headroom.
- Follow the Danish tax proceedings and additional assessments, as well as the German antitrust investigation and potential liquidity exposure.
- Assess whether North America margin gains can offset International mix and currency pressure, and whether integration costs decline as forecast.
- Review customer concentration, management-transition effects and the distinction between GAAP results and adjusted non-GAAP measures.